MedTrace Logo

Headache Inducing Characteristics and Possible Changes in Cerebral Blood Flow After Administration of PGE2

NCT00374530 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2007-08-01

No results posted yet for this study

Summary

Before, during and after intravenous administration of PGE2 we score/measure headache, rCBF, blood flow in the middle cerebral artery and diameter of superficial temporal artery and correlate that to known pathophysiology of headache to see if PGE2 is involved in headache pathophysiology.

Conditions

Interventions

DRUG

PGE2

Sponsors & Collaborators

  • Danish Headache Center

    lead OTHER

Principal Investigators

  • Troels Wienecke, MD · Danish Headache Center

Study Design

Allocation
RANDOMIZED
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2006-08-31

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00374530 on ClinicalTrials.gov